A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

Allergan

Status: Completed

Conditions: Macular Edema

Treatments: Drug: Dexamethasone Intravitreal Implant

Study type: Observational

Funder types: Industry

Identifiers

NCT01805323

CMA-OZU-12-001

Details and patient eligibility

About

This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX® was previously administered according to general clinical practice.

Enrollment: 101 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Retinal disease involving macular edema
• Received at least one OZURDEX® injection

Exclusion criteria

• None

Trial design

101 participants in 1 patient group

All Participants

Description:

Patients with macular edema previously treated with dexamethasone intravitreal implant (OZURDEX®) according to general clinical practice.

Treatment:

Drug: Dexamethasone Intravitreal Implant